ICU Medical (NASDAQ:ICUI) Upgraded by StockNews.com to “Buy” Rating

StockNews.com upgraded shares of ICU Medical (NASDAQ:ICUI) from a hold rating to a buy rating in a research report released on Friday morning.

Other equities research analysts also recently issued reports about the stock. Jefferies Financial Group upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target on the stock in a research note on Wednesday, December 11th. Raymond James set a $97.00 target price on shares of ICU Medical in a research report on Wednesday, March 12th. One investment analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, ICU Medical has an average rating of “Buy” and an average price target of $168.67.

ICU Medical Price Performance

ICU Medical stock opened at $139.32 on Friday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. ICU Medical has a 52 week low of $93.36 and a 52 week high of $196.26. The stock has a market capitalization of $3.42 billion, a P/E ratio of -30.49 and a beta of 0.73. The stock has a fifty day moving average of $151.64 and a 200-day moving average of $162.65.

Institutional Investors Weigh In On ICU Medical

Several hedge funds have recently added to or reduced their stakes in the business. Arizona State Retirement System raised its stake in shares of ICU Medical by 1.0% during the fourth quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier’s stock valued at $1,044,000 after acquiring an additional 65 shares during the last quarter. Huntington National Bank raised its position in ICU Medical by 6.2% during the 4th quarter. Huntington National Bank now owns 1,402 shares of the medical instruments supplier’s stock worth $218,000 after purchasing an additional 82 shares during the last quarter. Equitable Trust Co. lifted its holdings in ICU Medical by 1.6% during the 4th quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier’s stock worth $822,000 after buying an additional 84 shares during the period. LPL Financial LLC grew its position in shares of ICU Medical by 2.0% in the 4th quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier’s stock valued at $747,000 after buying an additional 93 shares during the last quarter. Finally, Alliancebernstein L.P. increased its stake in shares of ICU Medical by 0.5% in the fourth quarter. Alliancebernstein L.P. now owns 26,107 shares of the medical instruments supplier’s stock valued at $4,051,000 after buying an additional 136 shares during the period. 96.10% of the stock is currently owned by institutional investors and hedge funds.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.